Identifying patients least likely to develop pulmonary hypertension allows physicians to focus on those with greater risk.
Genome-wide association study identifies two variants that may yield therapies for children with DMD.
Team science. Ongoing innovation. Brilliant minds. Here’s how The Cancer Genome Atlas spawned a revolution in cancer research and technology.
The cloud-based platform is a free tool that empowers clinicians and fosters collaboration to find new genetic mutations that cause heart disease.
What good is genomic data if it can’t be shared efficiently?
The first use of whole exome sequencing for monogenic causes of kidney stone disease reveals the diagnostic tool is ripe for clinical application.
Some subtypes of leukemia have a poor prognosis. Genomic studies are helping to identify these subtypes, leading to targeted therapies.
